Cognis' Exclusive Licensing Agreement with Natural ASA for TONALIN CLA Goes into Effect.Business Editors/Health/Medical Writers DUSSELDORF, Germany--(BUSINESS WIRE)--Feb. 14, 2003 Cognis to Further Expand TONALIN CLA CLA, n.pr See acid, conjugated linoleic. into Dietary Supplement Noun 1. dietary supplement - something added to complete a diet or to make up for a dietary deficiency diet - a prescribed selection of foods vitamin pill - a pill containing one or more vitamins; taken as a dietary supplement , Food Ingredient, Pharmaceutical and Cosmetic Markets Cognis, a global specialty chemicals and nutritional ingredients company, and Natural ASA Asa (ā`sə), in the Bible, king of Judah, son and successor of Abijah. He was a good king, zealous in his extirpation of idols. When Baasha of Israel took Ramah (a few miles N of Jerusalem), Asa bought the help of Benhadad of Damascus and , a Norwegian research and development company, have announced that the licensing agreement signed in August 2002 for TONALIN(R) brand conjugated linoleic acid Conjugated linoleic acid (CLA) refers to a family of many isomers of linoleic acid (at least 13 are reported), which are found primarily in the meat and dairy products of ruminants. As implied by the name, the double bonds of CLAs are conjugated. (CLA) will go into effect on February 15, 2003. The agreement grants Cognis an exclusive license to Natural ASA's CLA intellectual property, technology, and marketing, as well as an exclusive license for the use of the TONALIN(R) trademark. Patent rights licensed exclusively to Natural from the Wisconsin Alumni Research Foundation The Wisconsin Alumni Research Foundation is the nonprofit technology transfer office of the University of Wisconsin-Madison. It is a significant source of research support, independent of federal grants. (WARF WARF Wisconsin Alumni Research Foundation WARF Wide Aperture Research Facility WARF Wartime Active Replacement Factors WARF weighted-average risk factor WARF Wartime Attrition and Replacement Factors WARF Whylie Animal Rescue Foundation ) are part of the agreement. WARF, a not-for-profit organization based in Madison, offers intellectual property management services to the faculty of the University of Wisconsin. Natural ASA is the world's leading supplier of CLA and parent company of Natural Inc., based in Vernon Hills, IL. Now that the licensing agreement between Cognis and Natural is in effect, TONALIN(R) CLA will be sold and marketed under Cognis' Nutrition and Health Division. The company is seeking to expand TONALIN(R) CLA's market share in its primary marketing channel of dietary supplements, as well as advance the key markets of foods, cosmetics and pharmaceuticals. In conjunction with this expansion, Cognis anticipates the immediate launch of strategic sales and marketing programs to further solidify TONALIN(R) CLA as the leading dietary supplement of its kind. "We are pleased that the licensing agreement between Cognis and Natural is now in effect so we can begin implementing programs to increase TONALIN(R) CLA's visibility in the marketplace, and build upon its already impressive record of clinical substantiation," stated Paul Allen
Paul Gardner Allen (born January 21, 1953 in Seattle, Washington) is an American entrepreneur. With Bill Gates, he formed Microsoft. , Group Vice President, Cognis Nutrition and Health. "In 2003, Cognis will continue to strengthen TONALIN(R) CLA's brand equity in established marketing channels, developing marketing opportunities in new channels, and promoting credible research on CLA's multitude of promising health applications." TONALIN(R) CLA utilizes a new proprietary process that converts linoleic acid linoleic acid /lin·o·le·ic ac·id/ (lin?o-le´ik) a polyunsaturated fatty acid, occurring as a major constituent of many vegetable oils; it is used in the biosynthesis of prostaglandins and cell membranes. from safflower oil Noun 1. safflower oil - oil from safflower seeds used as food as well as in medicines and paints Carthamus tinctorius, false saffron, safflower - thistlelike Eurasian plant widely grown for its red or orange flower heads and seeds that yield a valuable oil into CLA which provides the highest activity available at 80 percent. It is the brand used in most clinical research confirming CLA's benefits for human health, including five published studies on CLA in the past 18 months. In the spirit of Natural ASA, Cognis will continue to fund important clinical studies with TONALIN(R) CLA and human health benefits. In 2003, results from a 12 month clinical study will be published demonstrating a beneficial role for TONALIN(R) CLA in body weight management. For information in North America about TONALIN(R) brand CLA, please call 800.673.3702 to place an order, e-mail cognis.custserv@cognis-us.com, or fax 513.482.3576. For information in Europe about TONALIN(R) brand CLA, call +49.211.794.9692, e-mail nutrition-and-health-europe@cognis.com, or fax +49.211.798.2390. For information in Asia Pacific about TONALIN(R) brand CLA, call +61.3.9584.4588. About CLA: CLA is a polyunsaturated polyunsaturated /poly·un·sat·u·rat·ed/ (-un-sach´er-at-ed) denoting a chemical compound, particularly a fatty acid, having two or more double or triple bonds in its hydrocarbon chain. , conjugated fatty acid Conjugated fatty acids are polyunsaturated fatty acids in which at least one pair of double bonds are separated by only one single bond, as follows: -C=C-C=C- See also
About Cognis: Cognis ( www.cognis.com ) is a worldwide supplier of innovative specialty chemicals and nutritional ingredients with almost 9,100 employees in close to 50 countries. The company has dedicated its activities to a high level of sustainability and delivers natural-source ingredients for food, nutrition and healthcare markets and serves major customers in the cosmetics, detergents and cleaners industries. Additionally, Cognis provides solutions for a number of other industries such as, coatings and inks, lubricants, textiles and plastics as well as agrosolutions and mining chemicals. Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and Schroder Ventures Life Sciences. In 2001, Cognis recorded sales of 3.1 billion euros and an operating profit Operating profit (or loss) Revenue from a firm's regular activities less costs and expenses and before income deductions. operating profit See operating income. of 174 million euros. In the first half-year of 2002, sales were 1.6 billion euros. Cognis Nutrition and Health, a business unit of Cognis Group, provides antioxidant antioxidant, substance that prevents or slows the breakdown of another substance by oxygen. Synthetic and natural antioxidants are used to slow the deterioration of gasoline and rubber, and such antioxidants as vitamin C (ascorbic acid), butylated hydroxytoluene , botanical and nature-based ingredients for dietary supplements; pharmaceuticals and healthcare; functional foods and medical nutrition; and animal nutrition. As a leader in food technology, Cognis manufactures emulsifiers, emulsifier-based compounds, and numerous other specialty products for the food industry worldwide. About Natural: Natural ( www.natural.no ), headquartered in Oslo, Norway, is a research and development company positioned between an external research network and the food/animal feed industries. Natural's objective is to develop high-value bioactive bi·o·ac·tive adj. Of or relating to a substance that has an effect on living tissue. bioactive having an effect on or eliciting a response from living tissue. patent-protected lipid products for licensing to global markets. The main markets are producers of animal feed, human food, and dietary supplements around the world. The research network consists of over 150 researchers connected to universities and research organizations, principally in the USA. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion